GENE ONLINE|News &
Opinion
Blog

BRCA
Licensing PARP Inhibitor
Japan Grants Orphan Drug Designation to Lynparza for Germline BRCA-mutated Pancreatic Cancer
2020-03-25
Trials & Approvals Breast Cancer
CFDA processes priority review of BGI’s BRCA1/2 gene testing kit
2018-07-11
In-Depth Breast Cancer
PARP inhibitors in cancer – BRCA or no BRCA
2018-07-03
Interviews DNA
Foresee the Future of Genetic Testing: Exclusive Interview of Kevin Kuo, Chief Executive of Gene Health Co., Ltd. – Part 2
2017-09-10
Interviews DNA
Foresee the Future of Genetic Testing: Exclusive Interview of Kevin Kuo, Chief Executive of Gene Health Co., Ltd. – Part 1
2017-09-05
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top